Preferred Name

Tesevatinib

ID

http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl#C62496

CAS_Registry

781613-23-8

code

C62496

Concept_In_Subset

http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl#C116977

http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl#C157712

http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl#C177537

http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl#C157711

http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl#C63923

http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl#C176424

http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl#C128784

http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl#C116978

Contributing_Source

CTRP

GDC

FDA

DEFINITION

An orally bioavailable small-molecule receptor tyrosine kinase (RTK) inhibitor with potential antineoplastic activity. Tesevatinib binds to and inhibits several tyrosine receptor kinases that play major roles in tumor cell proliferation and tumor vascularization, including epidermal growth factor receptor (EGFR; ERBB1), epidermal growth factor receptor 2 (HER2; ERBB2), vascular endothelial growth factor receptor (VEGFR), and ephrin B4 (EphB4). This may result in the inhibition of tumor growth and angiogenesis, and tumor regression.

Display_Name

Tesevatinib

FDA_UNII_Code

F6XM2TN5A1

FULL_SYN

XL647

TESEVATINIB

Tesevatinib

EXEL 7647

KD 019

4-Quinazolinamine, N-(3,4-dichloro-2-fluorophenyl)-6-methoxy-7-(((3aalpha,5beta,6aalpha)-octahydro-2-methylcyclopenta(c)pyrrol-5-yl)methoxy)-

KD019

Has_Target

http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl#C17319

http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl#C17293

http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl#C17068

Is_Value_For_GDC_Property

http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl#C1909

label

Tesevatinib

Legacy Concept Name

XL647

Maps_To

Tesevatinib

NCI_Drug_Dictionary_ID

386183

PDQ_Closed_Trial_Search_ID

386183

PDQ_Open_Trial_Search_ID

386183

Preferred_Name

Tesevatinib

prefixIRI

Thesaurus:C62496

prefLabel

Tesevatinib

PubMedID_Primary_Reference

22011666

Semantic_Type

Pharmacologic Substance

UMLS_CUI

C1541356

subClassOf

http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl#C1742

http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl#C1967

http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl#C129825

Delete Subject Author Type Created
No notes to display
Create New Mapping

Delete Mapping To Ontology Source
http://purl.obolibrary.org/obo/CHEBI_167674 Chemical Entities of Biological Interest Ontology / 生物相关的化学实体本体 LOOM